Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

NCT00355589 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

NCT03756103 ·Status: COMPLETED ·Phase: PHASE2

Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients

NCT04820907 ·Status: COMPLETED ·Phase: PHASE3

Ramipril - Hypertension

NCT00325806 ·Status: COMPLETED ·Phase: PHASE4

Replication of the ONTARGET Antihypertensive Trial in Healthcare Claims Data

NCT04354350 ·Status: COMPLETED

Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients

NCT04830449 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension

NCT00473174 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate Efficacy and Safety of a TCA108 in Participants ≥18 Years With Uncontrolled Hypertension

NCT07030101 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension

NCT05362110 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

NCT00153101 ·Status: COMPLETED ·Phase: PHASE4

Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril

NCT01258764 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of TELMINUVO to Stage 2 Hypertension

NCT01983735 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

NCT00553865 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

NCT02916602 ·Status: COMPLETED ·Phase: PHASE3

Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension

NCT00281593 ·Status: COMPLETED ·Phase: PHASE3

Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants

NCT01037530 ·Status: COMPLETED ·Phase: PHASE4

China Medical University Hospital (CMUH) Triapin Listing

NCT00841880 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate Hypertension

NCT00289406 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled

NCT02526875 ·Status: UNKNOWN ·Phase: PHASE4

Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension

NCT06091176 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure

NCT01005290 ·Status: TERMINATED ·Phase: PHASE2

Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)

NCT00157963 ·Status: COMPLETED ·Phase: PHASE4

A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension

NCT01518998 ·Status: COMPLETED ·Phase: PHASE2

An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event

NCT03099213 ·Status: COMPLETED ·Phase: PHASE4

Essential Hypertension

NCT01264692 ·Status: COMPLETED ·Phase: PHASE2